https://www.universiteitleiden.nl/en/events/2026/05/disease-modifying-therapies-in-parkinsons-disease
Disease-modifying therapies in Parkinson's disease - Leiden University
Prof.dr. GJ Groeneveld dr. P. Kremer
disease modifying therapiesparkinsonleidenuniversity
https://www.polkutx.com/
Polku Therapeutics | Disease-Modifying Therapies for Neurodegeneration
Polku Therapeutics develops first-in-class disease-modifying therapies for neurodegenerative diseases, targeting protein aggregation and neuroinflammation...
disease modifying therapiespolkutherapeuticsneurodegeneration
https://pmc.ncbi.nlm.nih.gov/articles/PMC9398078/
Disease-Modifying Therapies for Multiple System Atrophy: Where Are We in 2022? - PMC
Multiple system atrophy is a rapidly progressive and fatal neurodegenerative disorder. While numerous preclinical studies suggested efficacy of potentially...
disease modifying therapiesmultiple system atrophywhere are we
https://www.globenewswire.com/news-release/2025/08/05/3127078/28124/en/Alzheimer-s-Disease-Disease-Modifying-Therapies-Markets-2023-2025-2026-2030-Key-Marketed-Products-Clinical-Trials-Competitive-Scenario-and-R-D-Activities.html?code=unknown&aff_unique2=unknown
Alzheimer's Disease Disease-Modifying Therapies Markets,
Explore the growth potential of the Alzheimer's disease-modifying therapies (DMTs) market as lecanemab gains FDA approval in 2023. With several late-stage...
alzheimer s diseasemodifyingtherapiesmarkets
https://www.prnewswire.com/news-releases/disease-modifying-therapies-an-unmet-need-for-patients-with-diabetic-nephropathy-300465245.html
Disease-Modifying Therapies: An Unmet Need for Patients with Diabetic Nephropathy
/PRNewswire/ -- Decision Resources Group finds that approximately 66% of surveyed physicians in the United States and 70% in Europe (United Kingdom, France,...
disease modifying therapiesunmet needfor patients
https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2022.1050183/full
Frontiers | Multiple sclerosis-disease modifying therapies affect humoral and T-cell response to...
Background: The mRNA vaccines help protect from COVID-19 severity,however multiple sclerosis (MS) disease modifying therapies (DMTs) might affect the develop...
disease modifying therapies
https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2024.1477988/full
Frontiers | A review of recent clinical trials to evaluate disease-modifying therapies in the...
Cardiac amyloidosis (CA) is a serious condition that results in infiltrative cardiomyopathy and heart failure with preserved ejection fraction (HFpEF) that i...